statistical analysis of William's Design [Study As­sess­ment]

posted by dshah  – India/United Kingdom, 2022-02-18 11:26 (342 d 23:53 ago) – Posting: # 22797
Views: 1,184

(edited by dshah on 2022-02-18 16:27)

Dear Ahmed!

Particularly for EMA as per the guideline: - "In studies with more than two treatment arms (e.g. a three period study including two references, one from EU and another from USA, or a four period study including test and reference in fed and fasted states), the analysis for each comparison should be conducted excluding the data from the treatments that are not relevant for the comparison in question."
So you will need to show the calculations separately.
Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
32 visitors (0 registered, 32 guests [including 7 identified bots]).
Forum time: 11:20 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5